Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Guidance Document To-Do List Grows

Mar 12 2012

• By Brenda Sandburg

Related Content

FDA’s Guidance Document To-Do List

Jan 03 2011

Generics Joining The 12-Month Stability Data Club, But “When?” Is Big Question

Oct 31 2011

Track and Trace Standards Coming Shortly, FDA Says

Jan 02 2012

FDA Biosimilars Guidances Address Immunogenicity Studies, European Bridge Data, Analytics

Feb 13 2012

Can FDA Do The "Right Thing" On Transparency? Ask A Lawyer

May 19 2010

FDAAA Post-Marketing Requirements Growing As Commitments Decline

Aug 08 2011

ANDA User Fees Will Fund Public Relations-focused Studies On Palatability Of Generics

Dec 12 2011

DTC Pre-Review Guidance In The Works For Rx TV Ads, FDA’s Abrams Says

Nov 14 2011

FDA Guidance Policy Could Be Hurt By Ruling On Animal Drug Compounding

Sep 26 2011

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window